Roche Holding AG ROG.SW

What moved ROG.SW

1. 1

   Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker

   +0.10impact 2.6▲0.5%
2. 2

   Heart Attack Diagnostics Market to Reach $21.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research

   +0.40impact 1.4▲2.2%
3. 3

   Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help.

   +0.20impact 1.4▲0.5%
4. 4

   IEFA vs. SPDW: Broad International Exposure With Different Portfolio Designs

   +0.00impact 0.0▲0.9%
5. 5

   Breaking Up With U.S. Stocks? SPDW Offers Lower Costs and Higher Yield Than ACWX.

   +0.00impact 0.0▲0.1%

Profile

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Thomas Schinecker

Employees

103249

Country

CH

Roche Holding AG is a global healthcare company specializing in pharmaceuticals and diagnostics, with significant operations in Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international regions. Its comprehensive portfolio of pharmaceutical products addresses conditions across oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolism, ophthalmology, and respiratory health. Additionally, the company develops treatments for specific ailments such as anemia, dermatological conditions, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation. The diagnostics division offers a range of in-vitro tests essential for identifying numerous diseases, including cancer, diabetes, COVID-19, hepatitis, and human papillomavirus (HPV). Beyond tests, it also supplies crucial diagnostic instruments and reagents. Founded in Basel, Switzerland, in 1896, the company maintains its headquarters there.